Ximluci

Medicinal product

(Invented) name

Ximluci

Active substance (s)

Ranibizumabas

Strength

10 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

vartoti į stiklakūnį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01LA04, Ranibizumab

Marketing authorisation holder

STADA Arzneimittel AG, Vokietija

Date of authorisation

2022-11-09

Date of renewal

Documents

Ximluci mokomoji medziaga pacientams.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	1 ml
Ranibizumabas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109834	95941	1095941	flakonas	0,23 ml N1		Receptinis	EU/1/22/1691/001	Netiekiama	-	-	No	-	-
109835	95942	1095942	flakonas	0,23 ml N1 (+filtro adata)		Receptinis	EU/1/22/1691/002	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-11-09	Registruotas